In conclusion, CAPS ≥ 2 points, which takes age (≥60), CRP (≥5 mg/dL), and area of pulmonary infiltration on a chest X-ray (≥22%) into consideration, could effectively predict the occurrence of ARDS in patients with COVID-19 pneumonia. The gene discussed is CRP; the disease is cryopyrin-associated periodic syndrome.